Registered Owners
- View profile →
MEDIKON PRIMA LABORATORIES - INDONESIA
KAB. TANGERANG
NPWP: 013180096415000
owner
Direktorat Registrasi ObatValid
MELOXICAM
- BPOM Number
- GKL0614911310A1
- Approved
- 21 November 2024
- Expiry
- 21 October 2026
- Form
- TABLET; 7,5 MG
About This Registration
MELOXICAM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0614911310A1. Its current registration status is Valid, with the licence valid until 21 October 2026. The product is registered to MEDIKON PRIMA LABORATORIES - INDONESIA. BPOM first approved this registration in October 2021. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration Details
- Application
- Registrasi Obat
- Packaging
- DUS, 5 BLISTER @ 10 TABLET
- Department
- Direktorat Registrasi Obat
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
MEDIKON PRIMA LABORATORIES - INDONESIA
KAB. TANGERANG
primary
Ingredients (1)
MELOXICAM
Market Intelligence
- Owner Portfolio
- MEDIKON PRIMA LABORATORIES - INDONESIA holds 36 BPOM registrations
- Manufacturer Scale
- MEDIKON PRIMA LABORATORIES - INDONESIA produces 36 registered products
- Registration Age
- Registered for 4 years, 8 months
- Expiry Status
- Expires in 3 months
FDA Cross-Reference
via openFDA- Generic Name
- MELOXICAM
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- ORAL
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.
More products from MEDIKON PRIMA LABORATORIES - INDONESIA
Products in the same class
VESPERUM
-DKL0609216733A1
Approved: May 31, 2026SUSPENSI
IFARS PHARMACEUTICAL LABORATORIES - INDONESIAREGROU FORTE PLUS
-DKL2628606841A1
Approved: May 24, 2026CAIRAN OBAT LUAR
SURYA DERMATO MEDICA LABORATORIES - INDONESIABETAHISTINE MESILATE
-GKL2634017210A1
Approved: May 24, 2026TABLET
NOVAPHARIN - INDONESIALIPERCON
-DKL2615723517A1
Approved: May 24, 2026TABLET SALUT SELAPUT
ETERCON PHARMA - INDONESIA